Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06410495 · ClinicalTrials.gov registry record · NA
Digital Dyadic Family Based Intervention to Improve Sleep in Children with ODD and Their Parents: NiteCAPP SINCC (Pilot)
A NA study of Insomnia Chronic and Oppositional Defiant Disorder, sponsored by University of South Florida.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06410495: Recruiting NA study of Insomnia Chronic and Oppositional Defiant Disorder, sponsored by University of South Florida.
NCT06410495 is a NA study of Insomnia Chronic and Oppositional Defiant Disorder that is actively recruiting participants, run by University of South Florida. The registered enrollment target is 30 participants, below the 117-participant average among 16 other Insomnia Chronic trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06410495, a NA study of Insomnia Chronic and Oppositional Defiant Disorder, is actively recruiting participants, sponsored by University of South Florida.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
In this proposal a brief web-based cognitive behavioral treatment for insomnia (CBT-I) for children with oppositional defiant disorder (ODD) and their parents is iteratively adapted and tested for acceptability, feasibility, and preliminary efficacy.
Primary Outcome
Daily diaries filled out by children with parent assistance that measure sleep efficiency, sleep onset latency, and total sleep time. Diaries also measure child behavior.
Conditions Studied
Interventions
- BEHAVIORAL NiteCAPP SINCC
Study Locations (1)
Florida
- University of South Florida - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2024-05-01 |
| Est. Completion | 2025-12-01 |
| Phase | NA |
What NCT06410495 shows while recruiting
NCT06410495 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 117-participant average among 16 other Insomnia Chronic trials with a reported enrollment target (74% lower).
The record links to 2 conditions, with Insomnia Chronic appearing as the primary indexed condition, and to 1 intervention - of which NiteCAPP SINCC is the first listed.
NCT06410495 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06410495 about?
NCT06410495 is a clinical study titled "Digital Dyadic Family Based Intervention to Improve Sleep in Children with ODD and Their Parents: NiteCAPP SINCC (Pilot)". In this proposal a brief web-based cognitive behavioral treatment for insomnia (CBT-I) for children with oppositional defiant disorder (ODD) and their parents is iteratively adapted and tested for acceptability, feasibility, and preliminary efficacy.
What is the current status of trial NCT06410495?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-05-01. Estimated completion is 2025-12-01.
What conditions does trial NCT06410495 study?
This clinical trial studies the following conditions: Insomnia Chronic, Oppositional Defiant Disorder.
What interventions are being tested in trial NCT06410495?
The interventions under investigation include: NiteCAPP SINCC (BEHAVIORAL).
Who is sponsoring clinical trial NCT06410495?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06410495 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Insomnia Chronic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06410495's enrollment target sits among peer trials
30 12th of 16 higher than 3 of 16 other Insomnia Chronic trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Insomnia Chronic trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sleep Treatment Education Program for Cancer Survivors: STEP-Together
RECRUITING · NA
-
SLEEP-COPE: Sleep Intervention for Oppositional Children
RECRUITING · NA
-
Targeting Insomnia in School Aged Children With Autism Spectrum Disorder
RECRUITING · NA
-
Efficacy of Synchronous, Virtual Cognitive Behavioral Therapy for Insomnia Across Phases of Cancer Survivorship
RECRUITING · NA
-
Web-based Cognitive Behavioral Treatment for Insomnia in Dementia Caregivers
RECRUITING · NA
-
Sleep Learning Education and Empowerment for Older Korean Immigrants
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI